Attachment 01_Product Description.pdf

PDF 114 KB Posted

Attached to
BioFire Respiratory 2. 1 (RP2. 1) Panel with SARS-CoV-2 (COVID-19) Federal contract opportunity
Solicitation number
FA8052-20-R-0026
Issued by
Department of the Air Force Materiel Command Installation and Mission Support Center Installation Contracting Agency

About this file

This document is a combined synopsis and solicitation for a federal contract opportunity to provide BioFire Respiratory 2.1 (RP2.1) Panels with SARS-CoV-2. The solicitation is seeking proposals to supply BioFire Respiratory 2.1 (RP2.1) Panels that can detect SARS-CoV-2 as well as 21 additional respiratory pathogens, and that are compatible for use on BioFire 2.0, BioFire Torch, and other BioFire analyzers. Distribution is to be made according to the attached physical address and delivery schedule. The requirement is issued by the Department of the Air Force Materiel Command Installation and Mission Support Center Installation Contracting Agency. The associated NAICS code is 325413 for in-vitro diagnostic substance manufacturing, with a size standard of 1,250 employees. Proposals are requested through this announcement, with no written solicitation to be issued. Successful negotiations will be required prior to any contract award.

View the file

Other files for this federal contract opportunity

Other files attached to BioFire Respiratory 2. 1 (RP2. 1) Panel with SARS-CoV-2 (COVID-19), newest first.
File Type Posted
Attachment 02_Physical Addresses_Delivery Schedule.xlsx XLSX spreadsheet
Attachment 00_Combined Synopsis_Solicitation.pdf PDF
Attachment 03_Provisions_Clauses.pdf PDF

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

SPECIFICATIONS/SALIENT CHARACTERISTICS

14 September 2020

1. This is a product description for BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2.

The BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 should not only detect SARS- CoV-2, but also detect 21 additional respiratory pathogens to help clinicians quickly rule in and rule out other common causes of respiratory illness. Furthermore, the BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 shall be compatible for use on both the BioFire 2.0, BioFire Torch, and/or other BioFire® analyzers.

2. Distribution shall be made in accordance with the attached physical address and delivery schedule (Physical Addresses_Delivery Schedule).

File details come from the government source that posted it. Updated .